期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
重组人脑利钠肽治疗难治性心力衰竭的临床效果
1
作者 李红磊 《河南医学研究》 CAS 2020年第21期3946-3948,共3页
目的观察重组人脑利钠肽治疗难治性心力衰竭(RHF)的临床效果。方法选取2018年2月至2019年1月通许县人民医院收治的82例RHF患者,依据随机数表法分为对照组和研究组,各41例。在常规治疗基础上,对照组接受培哚普利治疗,研究组接受重组人脑... 目的观察重组人脑利钠肽治疗难治性心力衰竭(RHF)的临床效果。方法选取2018年2月至2019年1月通许县人民医院收治的82例RHF患者,依据随机数表法分为对照组和研究组,各41例。在常规治疗基础上,对照组接受培哚普利治疗,研究组接受重组人脑利钠肽联合培哚普利治疗。比较两组疗效,治疗前、治疗8周后心功能指标[心率(HR)、左心室射血分数(LVEF)、每搏量(SV)、心输出量(CO)]和血清学指标[肌钙蛋白T(TnT)、N末端B型脑钠肽(NT-pro BNP)、C反应蛋白(CRP)],不良反应发生率。结果两组治疗总有效率比较,研究组[90.24%(37/41)]高于对照组[73.17%(30/41)](P<0.05)。与对照组比较,治疗8周后研究组HR、TnT、NT-pro BNP、CRP水平较低,LVEF、SV、CO较高(均P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论重组人脑利钠肽治疗RHF效果显著,能有效降低血清TnT、NT-pro BNP、CRP水平,改善心功能,且安全性高。 展开更多
关键词 难治性心力衰竭 重组人脑利钠肽 培哚普
下载PDF
氟茚二酮(Previscan~)过敏反应:皮肤斑贴试验阳性(法语)
2
作者 Frouin E. Roth B. +2 位作者 Grange A. J.-C. Guillaume 李晓莉 《世界核心医学期刊文摘(皮肤病学分册)》 2006年第4期29-30,共2页
Introduction. Fluindione (Previscan ) is an oral anticoagulant belonging to the vitamin K antagonist class and is very widely used in France. While bleeding is a common complication, severe immunoallergic reactions ... Introduction. Fluindione (Previscan ) is an oral anticoagulant belonging to the vitamin K antagonist class and is very widely used in France. While bleeding is a common complication, severe immunoallergic reactions are less frequent. The authors report a case of drug-induced hypersensitivity syndrome. Case report. A 75 year-old woman was hospitalized for diffuse erythematous papular rash associated with facial oedema. These symptoms appeared 3 weeks after the beginning of treatment with fluindione, allopurinol and perindopril. Laboratory tests showed hyperleukocytosis, mixed hepatitis and moderate renal failure, with the entire picture being evocative of drug-induced hypersensitivity reaction. The eruption was associated with eosinophilia, hepatic cytolysis with cholestasis, and acute renale failure. While allopurinol and perindopril were stopped definitively, fluindione was only suspended temporarily following overdosage. On reintroduction, rapid recurrence of clinical and biologic signs was observed with increased severity. The skin rash resolved completely on withdrawal of the drug. Patch tests performed later were positive for fluindione and negative for allopurinol and perindopril. Discussion. These manifestations were consistent with the diagnosis of drug-induced hypersensitivity syndrome due to fluindione. Very few cases have been described with fluindione despite widespread prescription of the treatment is in France. While there may be no skin involvement, immunoallergic signs such as fever, hepatitis and acute tubular interstitial nephritis have been described with fluindione and these may be related to this syndrome (DRESS-Drug Reaction with Eosinophilia and Systemic Symptoms). Skin patch testing, which is easily performed, can be extremely helpful in determining a causal relationship with medication. 展开更多
关键词 皮肤斑贴试验 Previscan 茚二酮 别嘌呤醇 致敏药物 药物反应 红色斑丘疹 面部水肿 培哚普
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部